| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Regulatory Compliance > Earned Monopolies: Are They Really Bad? Re-Thinking Our Anti-Trust Laws |
|
Top Articles - Earned Monopolies: Are They Really Bad? Re-Thinking Our Anti-Trust Laws
There are many types of Monopolies in Business, Commerce and Industry. Most of the Monopoli According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product es that we see are actually created by the Government itself. For one our patent laws enabl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in a company a temporary Monopoly on new emerging technologies, which allows them a head star lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t in trade for putting capital into developing such technologies. Utility Companies also s here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe em to have a lock down on things in the energy sector. Municipalities offer guaranteed mark d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ets to the lowest bidder for cable TV, refuse, water and other services by allowing compani ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s to bid on the franchise for the area. Then there are the dynamic entrepreneurial compani easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi es, which grow to serve the market and customers vote for them as they become a near Monopo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically y and you would agree that is totally fair correct? Yes, absolutely. There is nothing wrong and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ with a Starbucks, Wal-Mart or Microsoft. Of course if our anti-trust regulators have anyth ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ng to say about that or impose their “unfair motif” to the winners of society and commerce ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a then indeed there will be a firestorm over it. Why is this happening? Well, there are soci dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lists amongst us who want to make everything fair and every person and business equal in ev cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ery way. They will say it is not fair that Starbucks has better management or it is not fai tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen that Microsoft works hardest or that Wal-Mart is too efficient. Of course that is fair, bu t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel t it is hard to compete against people or companies who are dedicated to their endeavors. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nfortunately, this is where we are headed and the folks at the Federal Trade Commission are y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products a disaster to free-markets as they do not know the difference between the ground and their . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rears. Where their heads are stuck presently. Perhaps this article will give food for thoug elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ht in 2007, so we do not end up thinking; why are we in the food line for potatoes some day tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Do not play the game of blame and shame The Advantage of Selling via Internet
|